USPTO Allows Claims in Alnylam RNAi Patent Application

The application, No. 20070275465, is entitled, "Double-Stranded Ribonucleic Acid with Increased Effectiveness in an Organism."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories